MFN Partners Management, LP - Q3 2023 holdings

$2.98 Billion is the total value of MFN Partners Management, LP's 13 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 7.1% .

 Value Shares↓ Weighting
XPO  XPO INC$946,343,050
+26.5%
12,675,3690.0%31.77%
+30.8%
LAD  LITHIA MTRS INC$458,079,571
-2.9%
1,551,0770.0%15.38%
+0.4%
PFSI  PENNYMAC FINL SVCS INC NEW$301,817,347
-5.3%
4,531,7920.0%10.13%
-2.1%
FCNCA SellFIRST CTZNS BANCSHARES INC Ncl a$272,739,502
+6.3%
197,623
-1.2%
9.16%
+9.9%
 RXO INC$250,085,030
-13.0%
12,675,3690.0%8.40%
-10.0%
OXYWS  OCCIDENTAL PETE CORP*w exp 08/03/202$246,118,450
+15.9%
5,690,6000.0%8.26%
+19.8%
HCA  HCA HEALTHCARE INC$189,207,324
-18.9%
769,1980.0%6.35%
-16.2%
LBTYK  LIBERTY GLOBAL PLC$124,471,898
+4.4%
6,706,4600.0%4.18%
+8.0%
 COINBASE GLOBAL INCnote 0.500% 6/0$103,481,687
-0.1%
136,953,0000.0%3.47%
+3.3%
BHC  BAUSCH HEALTH COS INC$49,320,000
+2.8%
6,000,0000.0%1.66%
+6.3%
 IVANHOE ELECTRIC INC$30,382,973
-8.7%
2,553,1910.0%1.02%
-5.6%
 WARBY PARKER INC$6,088,856
+12.6%
462,6790.0%0.20%
+15.9%
 CYCLERION THERAPEUTICS INC$576,164
-17.3%
169,4600.0%0.02%
-17.4%
GOOGL ExitALPHABET INCcap stk cl a$0-2,019,183
-100.0%
-7.85%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XPO LOGISTICS INC20Q3 202331.8%
LIBERTY GLOBAL PLC- C18Q3 202318.6%
CYCLERION THERAPEUTICS INC16Q1 20232.7%
HCA HEALTHCARE INC15Q3 202310.9%
CHENIERE ENERGY INC13Q4 202119.2%
OCCIDENTAL PETROLEUM CORP13Q3 202310.5%
PENNYMAC FINL SVCS INC NEW11Q3 202312.2%
ALPHABET INC-CL A9Q2 202312.9%
LITHIA MTRS INC8Q3 202316.0%
META PLATFORMS INC7Q4 202114.1%

View MFN Partners Management, LP's complete holdings history.

Latest significant ownerships (13-D/G)
MFN Partners Management, LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Foley Trasimene Acquisition Corp.March 15, 20215,000,0004.8%
Cyclerion Therapeutics, Inc.February 12, 20212,427,6777.2%
Foley Trasimene Acquisition Corp.February 12, 202114,000,00013.5%
Foley Trasimene Acquisition IISold outFebruary 12, 202100.0%
Aclaris Therapeutics, Inc.July 22, 20201,895,6774.5%

View MFN Partners Management, LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-04-17
13F-HR2024-02-13
42024-02-12
42024-02-06
42023-11-24
42023-11-20
42023-11-15
13F-HR2023-11-13
13F-HR2023-08-11
42023-08-01

View MFN Partners Management, LP's complete filings history.

Compare quarters

Export MFN Partners Management, LP's holdings